The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
Clinical trial NCT06036966 · UNKNOWN
Trial details
- NCT number
- NCT06036966
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-16
- Primary completion
- 2025-07-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.